Neofollics

Neofollics is a Dutch haircare company specialising in products aimed at hair loss, thinning and scalp health. It was founded in 2015 by Maik van den Berg, who had experienced hair loss himself, and trades under the fuller name Neofollics Hair Technology [2]. The company is independent and remains active, with new product lines and award nominations recorded through 2025 and into 2026.

The brand sits in the cosmeceutical end of haircare: it builds its range around a proprietary complex called Neoxyl and frames its products as clinically supported treatments rather than ordinary cosmetics. Its products are sold internationally and, according to the independent Dutch hair foundation Haarstichting, are recommended by pharmacists, trichologists and dermatologists [12].

Neofollics traces its beginnings to its founder's own search for a hair-loss solution. Van den Berg has said that conventional dermatology offered him no answer, and that the treatments he did find fell into two unsatisfactory groups: cosmetic products that used active ingredients at low concentrations to keep costs down, and pharmaceutical options whose side effects discouraged long-term use [2]. That gap, in the company's telling, prompted him to develop what it describes as effective and honest products built around proven ingredients.

The Netherlands as the country of origin is well established. Beyond the company's own account, the third-party Haarstichting describes Neofollics as "a Dutch company that has specialized in products against hair loss," and a CB Insights business profile likewise places the firm in the Netherlands and dates its founding to 2015 [12][11].

After its 2015 launch with a hair-growth line, the company expanded its catalogue steadily over the following decade. It introduced an anti-grey range in 2019, opened an official webshop and added a beard-growth line in 2020, and launched a scalp-therapy range in 2022 [3]. The same period brought a series of Dutch business recognitions, including a place on the Chamber of Commerce (KVK) Innovation Top 100 in 2020 and repeated appearances in the FD Gazellen awards for fast-growing companies.

In 2024 the company exhibited for the first time at Cosmoprof Worldwide in Bologna and appeared in the Financial Times FT1000 ranking of fast-growing European firms. In 2025 it marked its first decade. Tied to that anniversary, Neofollics stated it had helped more than one million people with hair and scalp concerns [3] — a figure larger than the "over 300,000 people worldwide" cited on the older Haarstichting profile, a difference the two sources attribute to different dates and scope [12].

The range is organised into four areas: hair growth, scalp therapy, beard growth and anti-grey, spanning lotions, shampoos, conditioners, serums, supplement tablets and scalp- and beard-roller devices. Signature products include the Hair Growth Stimulating Lotion, the Hair Growth Stimulating Shampoo and a Beard Growth Stimulating Serum.

At the centre of the line is Neoxyl, which the company describes as a proprietary complex of molecules, peptides and botanical extracts and uses at a 7% concentration in some products. Named components include Aminexil, adenosine and the brown-seaweed extract Ecklonia cava, the last presented as a DHT inhibitor (DHT is a hormone linked to hereditary hair loss). A separate ingredient, Greyverse — the peptide palmitoyl tetrapeptide-20 — anchors the anti-grey products.

Neofollics supports its products with a set of clinical and consumer-test claims that are stated by the company rather than independently published. The most prominent is that Neoxyl is "41% more effective than Minoxidil in promoting the growth of dermal papilla cells," a claim the brand attributes to in-vitro testing [6]. The company's own studies index lists four product tests described as consumer trials, and notes no participant counts, durations or named research institutes on the overview page itself.

The products are positioned as free of sulfates and parabens and are described by the company as made in the Netherlands [3]. Neofollics also says it works with research laboratories and biotechnology companies, though it does not name specific institutions.

Neofollics' public recognition is drawn largely from Dutch and European business and beauty awards. In 2024 the company was ranked fifth in the "Pharmaceuticals & Cosmetics" category of the Financial Times FT1000, and its Anti-Grey Hair Serum reached finalist status at the Cosmoprof Award in Bologna [8]. It reports repeated FD Gazellen awards for fast-growing Dutch companies across several years and a second-place finish at the Dutch Beauty Awards 2026.

The company sells directly through its own webshop and through a mix of pharmacy and specialist channels. Named partners include the pharmacy distributor Oriola, the pharmacy chain Boots and several country-specific retail and trichology partners. According to one independent reviewer, Neofollics rarely runs discount promotions, which the reviewer read as a sign of stable, premium pricing [13].

Neofollics is an active, independently run company. Its most recent recorded activity includes the 2025 first-decade milestone and a second-place placing at the Dutch Beauty Awards 2026. The company states it operates in more than 40 countries; some of its own pages and the Haarstichting profile give the lower figure of 30, a discrepancy that likely reflects pages updated at different times as its market reach grew [1][12].